This article needs additional citations for verification. (December 2022) |
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Terramycin |
Pregnancy category |
|
Routes of administration | By mouth, topical (eye drop) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 6–8 hours |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
PDB ligand | |
E number | E703 (antibiotics) |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.103 |
Chemical and physical data | |
Formula | C22H24N2O9 |
Molar mass | 460.439 g·mol−1 |
3D model (JSmol) | |
Melting point | 181 to 182 °C (358 to 360 °F) |
| |
| |
(verify) |
Oxytetracycline is a broad-spectrum tetracycline antibiotic, the second of the group to be discovered.
Oxytetracycline works by interfering with the ability of bacteria to produce essential proteins. Without these proteins, the bacteria cannot grow, multiply and increase in numbers. Oxytetracycline therefore stops the spread of the infection, and the remaining bacteria are killed by the immune system or eventually die.
Oxytetracycline active against a wide variety of bacteria. However, some strains of bacteria have developed resistance to this antibiotic, which has reduced its effectiveness for treating some types of infections.
Oxytetracycline is used to treat infections caused by Chlamydia, such as psittacosis, trachoma, and urethritis, and infections caused by Mycoplasma organisms, such as pneumonia.
Oxytetracycline is used to treat acne, due to its activity against the bacteria on the skin that influence the development of acne (Cutibacterium acnes). It is used to treat flare-ups of chronic bronchitis, due to its activity against Haemophilus influenzae. Oxytetracycline may be used to treat other rarer infections, such as those caused by a group of microorganisms called rickettsiae (e.g., Rocky Mountain spotted fever). To make sure the bacteria causing an infection are susceptible to it, a tissue sample is usually taken; for example, a swab from the infected area or a urine or blood sample.[citation needed]
Oxytetracycline was patented in 1949 and came into commercial use in 1950.[1] It is on the World Health Organization's List of Essential Medicines as an alternative to tetracycline.[2]